Lyrica — Class II drug recall D-0649-2016

Terminated recall by Pfizer Inc., reported 2016-02-10, distributed nationwide. FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potent

Recall number	`D-0649-2016`
Product type	Drug
Classification	Class II
Status	Terminated
Voluntary or mandated	Voluntary
Recalling firm	Pfizer Inc., New York, NY, United States
Recall initiated	2016-01-11
Classified	2016-02-01
Reported by FDA	2016-02-10
Terminated	2017-04-24
Distributed	Nationwide (US)
Quantity	116,400 bottles
NDC	`00071-1012`, `00071-1012-68`, `00071-1013`, `00071-1013-41`, `00071-1013-68`, `00071-1014`, `00071-1014-41`, `00071-1014-68`, `00071-1015`, `00071-1015-41`, `00071-1015-68`, `00071-1016`, `00071-1016-41`, `00071-1016-68`, `00071-1017`, `00071-1017-68`, `00071-1018`, `00071-1018-68`, `00071-1019`, `00071-1019-68`, `00071-1020`, `00071-1020-01`
Lot numbers	`M07862`, `M07865`
Expiration dates	`2018-05`, `2018-06`

Product

Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68

Reason for recall

FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0649-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.